Complete Genomics Launches Full Sequencing Platforms at Biotech Showcase™ 2023
January 10, 2023
SAN FRANCISCO -- Complete Genomics, Inc. (https://completegenomics.mgiamericas.com/), a subsidiary of MGI Tech Co., Ltd. ("MGI"), today unveiled its full sequencing platforms at Biotech Showcase during JP Morgan Healthcare Conference Week 2023. Rade Drmanac, PhD, Chief Scientific Officer, announced "free three-month trial" program and "reagent rental leasing" program, giving customers the opportunity to experience the quality and reliability of [...]
CALIBRE SCIENTIFIC ACQUIRES DYNALAB
January 10, 2023
CALIBRE SCIENTIFIC ACQUIRES DYNALAB, A U.S. DISTRIBUTOR AND MANUFACTURER OF LABORATORY SUPPLIES AND CONSUMABLES LOS ANGELES, CA — Calibre Scientific is pleased to announce the acquisition of Dynalab Corp. (the “Company”), a Rochester, NY based distributor and manufacturer of laboratory plastics, consumables, equipment, supplies and custom fabricated products serving the scientific, industrial, agricultural, water, pharma [...]
January 10, 2023
Imaris 10.0 revolutionises the well-known and trusted Filament Tracer, which has been used by the neuroscience community for over 15 years, leading to almost 700 scientific papers. The new 10.0 Filament Tracer combines the versatility of an Autopath intensity-based method with a unique machine learning approach, providing the most flexible tool on the market for [...]
NETRI / Axol Bioscience Press Release January 10th 2023
January 10, 2023
NETRI and Axol Bioscience announce a strategic partnership to launch organs-on-chip kits including both NETRI’s neuro-organs-on-chip devices and Axol’s human induced pluripotent stem cells (hiPSC) with reagents to boost pharmaceutical industry access to organs on chip. NETRI is a French start-up that develops organs-on-chip technologies for pre-clinical neuroscience discovery. Axol Bioscience Ltd is a supplier [...]
January 10, 2023
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise Half Moon Bay, CA. – GenNext Technologies, Inc., an innovative provider of laboratory tools for advanced structural characterization of proteins, announced today that Dr. John L. Grant has joined its Board of Directors.Dr. Grant served as a highly valuable mentor for [...]
Park Systems Introduces Park NX-IR R300 Infrared Spectroscopy for Semiconductor Industry
January 9, 2023
Park Systems, a leading manufacturer of atomic force microscopy (AFM) and nano metrology systems, has introduced its newest product, the Park NX-IR R300, a nanoscale infrared spectroscopy (IR) system for industrial applications. Park NX-IR R300 is an infrared spectroscopy and atomic force microscopy integrated into one, for up to 300 mm semiconductor wafers. It provides [...]
LuminUltra participates in innovative wastewater surveillance pilot project at Toronto Pearson
January 9, 2023
FREDERICTON, CANADA – LuminUltra has partnered with the Greater Toronto Airports Authority (GTAA) to implement a cutting-edge, on-site laboratory to perform wastewater surveillance testing at Pearson International Airport. This pilot project, supported in part by funding from the National Research Council of Canada Industrial Research Assistance Program, is using LuminUltra’s technology to test for the [...]
BC Platforms Selected as Partner to Deliver key Singapore Population Health Study
January 9, 2023
First-in-kind Singapore study to deliver insights into heart disease, diabetes, cancer, and other chronic diseases BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced it has been selected as the platform of choice to analyse and manage data collected from the Health for Life in Singapore (HELIOS) study, which forms part of [...]
January 9, 2023
Making proteomics 100x more robust and 10x faster ODENSE, DENMARK – Evosep Aps – Evosep today announced that Novo Holdings A/S has become a minority shareholder in Evosep Aps with a US$ 40m investment to further Evosep’s technology and application portfolio for clinical proteomics. Evosep aims to improve quality of life and patient care by [...]
Novo Holdings invests in proteomics technology company, Evosep
January 9, 2023
COPENHAGEN, Denmark -- Novo Holdings, a leading international life science investor, today announced a $40m investment in Evosep, the bioscience company leading the standardisation of proteomics for clinical use. The proceeds from the investment by Novo Holdings will be used to advance clinical applications of proteomics enabled by Evosep's standardised liquid chromatography platform. The new funds will [...]

